<?xml version="1.0" encoding="UTF-8"?>
<p id="par0140">As presented in 
 <xref rid="fig0020" ref-type="fig">Fig. 4</xref> and Supplementary data 1, MDA content was markedly increased in the livers of mice in the APAP only-treated group (2.24 ± 0.28 μmol/mg) when compared to those in the control group (
 <italic>P</italic> &lt; 0.01). In the silymarin- (0.69 ± 0.12 μmol/mg) or 1400 mg/kg/day GMSYS-treated (0.71 ± 0.07 μmol/mg) groups, a significant decrease in the MDA content increased by APAP injection was observed (
 <italic>P</italic> &lt; 0.01). The administration of silymarin alone or 1400 mg/kg/day GMSYS alone caused no significant changes in MDA content compared to that of the control group.
</p>
